Precigen, Inc. (PGEN)
7.17
-0.03
(-0.42%)
USD |
NASDAQ |
Aug 24, 16:00
7.34
+0.17
(+2.37%)
Pre-Market: 08:02
Precigen Shareholders Equity (Quarterly) : 43.58M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 43.58M |
| March 31, 2026 | 20.24M |
| December 31, 2025 | 20.91M |
| September 30, 2025 | 41.87M |
| June 30, 2025 | -5.896M |
| March 31, 2025 | 15.46M |
| December 31, 2024 | 66.73M |
| September 30, 2024 | 55.38M |
| June 30, 2024 | 43.17M |
| March 31, 2024 | 97.02M |
| December 31, 2023 | 118.50M |
| September 30, 2023 | 147.68M |
| June 30, 2023 | 166.21M |
| March 31, 2023 | 184.13M |
| December 31, 2022 | 126.26M |
| September 30, 2022 | 142.53M |
| June 30, 2022 | 55.65M |
| March 31, 2022 | 73.84M |
| December 31, 2021 | 107.35M |
| September 30, 2021 | 131.25M |
| June 30, 2021 | 159.20M |
| March 31, 2021 | 174.80M |
| December 31, 2020 | 67.17M |
| September 30, 2020 | 58.55M |
| June 30, 2020 | 49.54M |
| Date | Value |
|---|---|
| March 31, 2020 | 87.23M |
| December 31, 2019 | 71.71M |
| September 30, 2019 | 228.42M |
| June 30, 2019 | 279.22M |
| March 31, 2019 | 313.03M |
| December 31, 2018 | 362.86M |
| September 30, 2018 | 539.40M |
| June 30, 2018 | 549.75M |
| March 31, 2018 | 553.11M |
| December 31, 2017 | 533.63M |
| September 30, 2017 | 533.61M |
| June 30, 2017 | 550.87M |
| March 31, 2017 | 528.54M |
| December 31, 2016 | 560.24M |
| September 30, 2016 | 600.47M |
| June 30, 2016 | 619.23M |
| March 31, 2016 | 664.93M |
| December 31, 2015 | 694.08M |
| September 30, 2015 | 718.29M |
| June 30, 2015 | 474.84M |
| March 31, 2015 | 640.67M |
| December 31, 2014 | 384.76M |
| September 30, 2014 | 358.36M |
| June 30, 2014 | 373.26M |
| March 31, 2014 | 415.90M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Geron Corp. | 218.61M |
| Elicio Therapeutics, Inc. | 7.937M |
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| Anika Therapeutics, Inc. | 137.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 170.30M |
| Total Liabilities (Quarterly) | 126.72M |
| Debt to Equity Ratio | 2.257 |
| Current Ratio | 4.578 |
| Net Debt Paydown Yield | -0.91% |